Skip to content
Life Sciences Series A Founded 2015

Hudson River Biotechnology

Developer of DNA-free CRISPR technology for crop resilience and yield improvement. The technology optimizes plant breeding to power and protect future crops. It offers a DNA-free CRISPR method that overcomes traditional limitations. The BioMaas platform allows for multi-trait targeting and scalable automation. Products are completed efficiently once the BioMaas platform has been implemented. The company was founded…

📍 Wageningen, Netherlands · Genomics,

Funding snapshot

Last roundSeries A
Amount$6M
Date9 April 2024
Total raised$6M
Team size22

About

Developer of DNA-free CRISPR technology for crop resilience and yield improvement. The technology optimizes plant breeding to power and protect future crops. It offers a DNA-free CRISPR method that overcomes traditional limitations. The BioMaas platform allows for multi-trait targeting and scalable automation. Products are completed efficiently once the BioMaas platform has been implemented. The company was founded in 2015 and headquartered in Wageningen, Netherlands. It has raised $5.9M in series a funding, with backing from Europa, Oost NL, Eurogenetic, Bridford Group, and others. The company operates in the Life Sciences - Genomics, Life Sciences - Life Sciences Platforms and Tools, Food and Agriculture Tech - Crop Tech space. Its offerings span Genomics - Applied Genomics - Agrigenomics.

Business model

Genomics > Applied Genomics > Agrigenomics,

Life Sciences Platforms and Tools > Research Services > Genomics,

Crop Tech > Farm Inputs > Plant Breeding > Technology Providers

Institutional investors

Europa Oost NL Eurogenetic Bridford Group EIC Fund

Backed by funds in our directory

Latest coverage

No articles yet.

Raising like Hudson River Biotechnology?

Analyze your pitch deck before your next raise.

Analyze My Deck →